rare diseases Archives - Express Pharma

CDSCO approves AstraZeneca’s anti-complement medicine Eculizumab

East Ocyon Bio closes $4.2M Seed round led by Aeravti Ventures and Micro Labs

Lupin appoints Claus Jepsen as President of Global Specialty

Lupin partners with Celnova Pharma to distribute NaMuscla in Argentina and Colombia

US approves first gene therapy for children with rare genetic disease

Innovations paving the way for drug discovery of rare diseases

India’s fight against rare diseases needs more focus on awareness and diagnosis: GlobalData

Our collaborations with Govt of India focus on building resilient healthcare systems

Zydus gets Orphan Drug Designation from USFDA for ZYIL1 to treat Cryopyrin Associated Periodic Syndrome

Xentria gets US FDA orphan drug designation for XTMAB-16 in sarcoidosis